Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/362870


Medicare Part D - Outlook for 2007


Description: The Medicare Modernization Act’s most significant achievement is the introduction of Medicare Part D, a wide-ranging new outpatient prescription drug benefit. The massive increase in the number of Medicare Part D plans in 2007 demonstrates the health insurance industry’s commitment to this new program. Lower premiums, zero deductibles, and an expansion of coverage in the coverage gap are all good news for beneficiaries. However, these changes reflect the intense struggle among insurers to gain an advantage in a highly competitive market.

Get the Answers You Need to Shape Your Strategy

Ninety percent of Medicare beneficiaries are currently enrolled in a Medicare Part D plan or equivalent. However, the number of Medicare Part D plans will increase sharply in 2007. What strategies are insurers employing to gain a competitive advantage in this market?

The coverage gap is one of the most contentious features of Medicare Part D. Beneficiaries face unaffordable drug prices, and plans offering drug coverage in the gap carry steep premiums. The pharmaceutical industry is not immune to the effects of this initiative. How is the coverage gap threatening manufacturers of branded drugs?

Medicare beneficiaries with special needs were historically viewed as an unwelcome liability for health plans. However, the Medicare Modernization Act introduced a risk adjustment model that offers greater rewards for managing an increasing number of chronic disorders through special needs plans (SNPs). What is the projected outlook for SNPs? Which insurers are at the forefront of this trend?

The Medicare fee-for-service system is structured and financed to manage acute care episodes, not to manage and support individuals with progressive chronic diseases. However, a demonstration project called Medicare Health Support aims to improve the quality of care for beneficiaries who have multiple chronic illnesses. What are the components of this initiative? What is the outlook for the Medicare disease management market?

Scope
- Medicare Modernization Act: overview and key changes in 2007.
- Current trends in available plans: prescription drug plans, Medicare advantage plans, employer-sponsored health plans, special needs plans, and Medicare medical savings accounts.
- Disease management: details the development of a demonstration project called the Medicare Health Support Program.
- Outlook and implications: how these trends are poised to affect the biopharmaceutical industry.


Contents: Executive Summary 3
Strategic Considerations 3
Stakeholder Implications 3
Overview 4
Key Changes in 2007 5
Employer-Sponsored Health Plans 8
Dual Eligible Beneficiaries 12
Special Needs Plans 13
Disease Management 15
Medicare Medical Savings Accounts 18
Sidebar: HealthSpring: A Regional Player Goes National 19
Outlook and Implications 20

Tables
1.Key Features of Standard Medicare Part D Drug Benefit, 2006 and 2007 6

Figures
1. Enrollment in Medicare Part D-Related Plans, January to June 2006 4
2. Sources of Prescription Drug Coverage for Medicare Beneficiaries, June 2006 5
3. Percentage of Standalone Prescription Drug Plans Charging Various Monthly Premiums,
2006 and 2007 7
4. Percentage of Medicare Advantage Plans Charging Various Monthly Drug Premiums,
2006 and 2007 8
5. Percentage of Standalone Prescription Drug Plans Levying Various Drug Deductibles,
2006 and 2007 9
6. Percentage of Medicare Advantage Plans Levying Various Drug Deductibles, 2006 and
2007 10
7. Percentage of Standalone Prescription Drug Plans Offering Various Levels of Drug
Coverage in the Coverage Gap, 2006 and 2007 11
8. Percentage of Medicare Advantage Plans Offering Various Levels of Drug Coverage
in the Coverage Gap, 2006 and 2007 12




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/362870

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 08/09/2008 05:11:48
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Medicare Part D - Outlook for 2007

Web Address:
http://www.researchandmarkets.com/reports/362870

Office Code:
OCHHIKLRUXU

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,146.00




Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 08/09/2008 05:11:48


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World